These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31614716)

  • 1. DockNmine, a Web Portal to Assemble and Analyse Virtual and Experimental Interaction Data.
    Gheyouche E; Launay R; Lethiec J; Labeeuw A; Roze C; Amossé A; Téletchéa S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DockThor-VS: A Free Platform for Receptor-Ligand Virtual Screening.
    Guedes IA; Pereira da Silva MM; Galheigo M; Krempser E; de Magalhães CS; Correa Barbosa HJ; Dardenne LE
    J Mol Biol; 2024 Sep; 436(17):168548. PubMed ID: 39237203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides.
    Tanwar S; Auberger P; Gillet G; DiPaola M; Tsaioun K; Villoutreix BO
    Data Brief; 2022 Jun; 42():108159. PubMed ID: 35496477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping small molecule binding data to structural domains.
    Kruger FA; Rostom R; Overington JP
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S11. PubMed ID: 23282026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building a virtual ligand screening pipeline using free software: a survey.
    Glaab E
    Brief Bioinform; 2016 Mar; 17(2):352-66. PubMed ID: 26094053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain-based small molecule binding site annotation.
    Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
    BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTiOpenScreen: a web server for structure-based virtual screening.
    Labbé CM; Rey J; Lagorce D; Vavruša M; Becot J; Sperandio O; Villoutreix BO; Tufféry P; Miteva MA
    Nucleic Acids Res; 2015 Jul; 43(W1):W448-54. PubMed ID: 25855812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening.
    Nagamine N; Shirakawa T; Minato Y; Torii K; Kobayashi H; Imoto M; Sakakibara Y
    PLoS Comput Biol; 2009 Jun; 5(6):e1000397. PubMed ID: 19503826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDT - Drug Discovery Tool: a fast and intuitive graphics user interface for docking and molecular dynamics analysis.
    Aureli S; Di Marino D; Raniolo S; Limongelli V
    Bioinformatics; 2019 Dec; 35(24):5328-5330. PubMed ID: 31304963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eModel-BDB: a database of comparative structure models of drug-target interactions from the Binding Database.
    Naderi M; Govindaraj RG; Brylinski M
    Gigascience; 2018 Aug; 7(8):. PubMed ID: 30052959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDTD: a web-accessible protein database for drug target identification.
    Gao Z; Li H; Zhang H; Liu X; Kang L; Luo X; Zhu W; Chen K; Wang X; Jiang H
    BMC Bioinformatics; 2008 Feb; 9():104. PubMed ID: 18282303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
    Bragina ME; Daina A; Perez MAS; Michielin O; Zoete V
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
    Mutowo P; Bento AP; Dedman N; Gaulton A; Hersey A; Lomax J; Overington JP
    J Biomed Semantics; 2016 Sep; 7(1):59. PubMed ID: 27678076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free resources to assist structure-based virtual ligand screening experiments.
    Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
    Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A.
    Çınaroğlu SS; Timuçin E
    J Mol Graph Model; 2019 Jan; 86():149-159. PubMed ID: 30366191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted Biological Activity of Purchasable Chemical Space.
    Irwin JJ; Gaskins G; Sterling T; Mysinger MM; Keiser MJ
    J Chem Inf Model; 2018 Jan; 58(1):148-164. PubMed ID: 29193970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
    Nowotka MM; Gaulton A; Mendez D; Bento AP; Hersey A; Leach A
    Expert Opin Drug Discov; 2017 Aug; 12(8):757-767. PubMed ID: 28602100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening.
    Zhou H; Cao H; Skolnick J
    J Chem Inf Model; 2021 Apr; 61(4):2074-2089. PubMed ID: 33724022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.